Published in
Elsevier, Journal of The American Academy of Dermatology, 2(79), p. 277-286.e10
DOI: 10.1016/j.jaad.2018.03.037
Links
Tools
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
Journal article published in 2018 by
Kim A. Papp,
Joseph F. Merola 
,
Alice B. Gottlieb,
Christopher E. M. Griffiths,
Nancy Cross,
Luke Peterson,
Christopher Cioffi,
Andrew Blauvelt
,
Alice B. Gottlieb,
Christopher E. M. Griffiths,
Nancy Cross,
Luke Peterson,
Christopher Cioffi,
Andrew Blauvelt
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 